Back to User profile » Dr Krishnendu Nandi
Papers published by Dr Krishnendu Nandi:
Faricimab for Refractory Neovascular Age-Related Macular Degeneration: Retrospective Real-World Evidence from India
Biswas RK, Sheth JU, Shrivastava V, Kaur J, Sinha S, Pal SS, Nandi K, Das S
Clinical Ophthalmology 2025, 19:3881-3887
Published Date: 21 October 2025
Biosimilar Versus Innovator Ranibizumab in Myopic CNVM: Comparative Real-World Outcomes- The BRIM Study
Chakraborty D, Sinha TK, Sinha S, Biswas RK, Maiti A, Nandi K, Rungta D, Bhattacharya R
Clinical Ophthalmology 2025, 19:3741-3747
Published Date: 10 October 2025
Clinical Evaluation of Faricimab in Real-World Diabetic Macular Edema in India- A Multicenter Observational Study
Chakraborty D, Das S, Maiti A, Sinha TK, Das A, Sheth J, Boral SK, Mondal S, Nandi K
Clinical Ophthalmology 2025, 19:269-277
Published Date: 25 January 2025
Transitioning from Aflibercept to Biosimilar Ranibizumab in Diabetic Macular Edema (DME): (The TRANSFORM-DME Trial) a Multicenter Observational Study
Chakraborty D, Sinha TK, Maiti A, Boral SK, Das A, Mondal S, Nandi K, Bhattacharya R
Clinical Ophthalmology 2024, 18:3449-3456
Published Date: 25 November 2024
Brolucizumab in Neovascular Age-Related Macular Degeneration – Indian Real-World Experience: The BRAILLE Study – Fifty-Two-Week Outcomes
Chakraborty D, Maiti A, Sheth JU, Mondal S, Boral S, Nandi K, Sinha TK, Das A
Clinical Ophthalmology 2022, 16:4303-4313
Published Date: 23 December 2022
Brolucizumab in Neovascular Age-Related Macular Degeneration – Indian Real-World Experience: The BRAILLE Study
Chakraborty D, Maiti A, Sheth JU, Boral S, Mondal S, Nandi K, Sinha T, Das A
Clinical Ophthalmology 2021, 15:3787-3795
Published Date: 7 September 2021